Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Not applicableLooking for participantsNCT05878964
What this trial is testing

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Who this might be right for
Lung CancerBreast CancerKidney Cancer+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 420
Not applicableUnknownNCT06112977
What this trial is testing

Restore-B: A Trial Comparing Prepectoral Implant-based Breast Reconstruction With and Without Mesh

Who this might be right for
Breast CancerRisk Reduction
University of Oxford 40
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Early research (Phase 1)Looking for participantsNCT05076760
What this trial is testing

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+7 more
Memgen, Inc. 40
Early research (Phase 1)Active Not RecruitingNCT04706962
What this trial is testing

TH1902 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorTNBC - Triple-Negative Breast CancerHormone Receptor-positive Breast Cancer+7 more
Theratechnologies 70
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Post-approval studies (Phase 4)Study completedNCT01781299
What this trial is testing

Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU

Who this might be right for
Breast CancerMastectomy
University of Pittsburgh 9
Post-approval studies (Phase 4)Study completedNCT01561287
What this trial is testing

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

Who this might be right for
Mastectomy Related LymphedemaBreast ReconstructionBreast Cancer
University of Kentucky 48
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Testing effectiveness (Phase 2)Study completedNCT02891759
What this trial is testing

Compare Outcomes Between Two Acellular Dermal Matrices

Who this might be right for
Breast Cancer
Washington University School of Medicine 320
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableUnknownNCT03494244
What this trial is testing

Evaluation of ADM Soft Tissue Reinforcement

Who this might be right for
Breast CancerSurgerySurgical Item, Retained
Massachusetts General Hospital 152
Not applicableStudy completedNCT04209010
What this trial is testing

Immediate Breast Reconstruction With Acellular Dermal Matrix

Who this might be right for
Breast CancerBreast Carcinoma in SituMammaplasty+1 more
Aarhus University Hospital 44
Not applicableUnknownNCT01679223
What this trial is testing

Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

Who this might be right for
Breast Cancer
University of Nevada, Las Vegas 60
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Next Page